Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014
Print

Breaking News

May 12, 2014
Will focus on late-stage development for hemophilia products  Read More »
May 12, 2014
Expands rare disease portfolio in GI/hepatic conditions  Read More »
May 12, 2014
Rudick bring expertise in MS programs  Read More »
May 12, 2014
Expands materials characterization testing services in St. Paul  Read More »
May 12, 2014
SAGE-547 enters clinical development  Read More »
May 12, 2014
Expands EHR capabilities  Read More »
May 9, 2014
To develop strategies to support Frenova’s dedication to renal research  Read More »
May 9, 2014
Will automate lab processes at R&D headquarters in India  Read More »
May 9, 2014
Will use CRISPR/Cas9 gene editing system for research applications   Read More »
May 9, 2014
Will provide early stage preclinical to commercial production  Read More »
May 9, 2014
Will combine adaptive trial capabilities with ICON’s technology platforms  Read More »
May 9, 2014
Aims to develop new experimental cancer models  Read More »
May 7, 2014
Will align Pharmorphix and BioTools for comprehensive chiral technology services  Read More »
May 7, 2014
Plans further investments in promising start-ups   Read More »
May 7, 2014
Aims to improve treatments for multi-drug resistant bacterial infections  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On